Human papillomavirus (HPV) vaccine, 9-valent and Lenvatinib Mesylate
Determining the interaction of Human papillomavirus (HPV) vaccine, 9-valent and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: human papillomavirus vaccine
Brand name: Gardasil 9, Cervarix
Synonyms: Papillomavirus (9-Valent) Vaccine (Human, Recombinant)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima (14 MG Daily Dose)
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima (18 MG Daily Dose)
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima (20 MG Daily Dose)
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima (24 MG Daily Dose)
- Human papillomavirus (HPV) vaccine, 9-valent-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Human Papillomavirus Vaccine
- Lenvatinib Mesylate-Human papillomavirus vaccine Intramuscular
- Lenvatinib Mesylate-Human Secretin
- Lenvatinib Mesylate-Humate-P
- Lenvatinib Mesylate-Humatin
- Lenvatinib Mesylate-Humatrope